Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJun 18, 2026
DataAggregated Company Financials
Companies9
  • 7D-2.4%
  • 3M9.3%
  • 1Y-17.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.4%, driven by a pullback from MedCap of 5.4%. On the other hand Level Bio is actually up 13%. Overall the industry is down 18% in 12 months. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 18 Jun 2026SEK 29.1bSEK 14.6b-SEK 871,304,353.0033.7x-33.4x2x
Sat, 16 May 2026SEK 28.9bSEK 14.6b-SEK 850,163,077.0036x-34x2x
Mon, 13 Apr 2026SEK 29.1bSEK 14.6b-SEK 971,664,077.0033.6x-30x2x
Wed, 11 Mar 2026SEK 27.3bSEK 14.6b-SEK 838,374,077.0032.9x-32.6x1.9x
Fri, 06 Feb 2026SEK 29.4bSEK 14.8b-SEK 578,515,427.0038x-50.9x2x
Sun, 04 Jan 2026SEK 30.1bSEK 14.9b-SEK 744,515,427.0046.9x-40.5x2x
Tue, 02 Dec 2025SEK 34.7bSEK 14.9b-SEK 744,515,427.0057.8x-46.6x2.3x
Thu, 30 Oct 2025SEK 38.2bSEK 14.8bSEK 117.3m55.8x325.3x2.6x
Sat, 27 Sep 2025SEK 34.4bSEK 14.7bSEK 61.3m55.5x561.4x2.3x
Mon, 25 Aug 2025SEK 35.4bSEK 14.7bSEK 59.9m58.8x591.4x2.4x
Wed, 23 Jul 2025SEK 45.4bSEK 16.7bSEK 444.3m61.8x102.2x2.7x
Fri, 20 Jun 2025SEK 45.9bSEK 16.6bSEK 405.8m73.2x113.1x2.8x
Sun, 18 May 2025SEK 46.4bSEK 16.6bSEK 415.3m45x111.8x2.8x
Tue, 15 Apr 2025SEK 36.0bSEK 16.6bSEK 609.4m38.6x59x2.2x
Thu, 13 Mar 2025SEK 36.5bSEK 16.6bSEK 614.9m38.5x59.3x2.2x
Sat, 08 Feb 2025SEK 43.4bSEK 17.0b-SEK 1,038,511,426.0043.1x-41.8x2.6x
Mon, 06 Jan 2025SEK 43.5bSEK 16.7b-SEK 1,152,911,426.0049.2x-37.8x2.6x
Wed, 04 Dec 2024SEK 42.3bSEK 16.7b-SEK 1,154,323,426.0049.8x-36.6x2.5x
Fri, 01 Nov 2024SEK 43.8bSEK 16.8b-SEK 956,465,491.0051.1x-45.8x2.6x
Sun, 29 Sep 2024SEK 48.3bSEK 16.7b-SEK 988,175,491.0059.2x-48.9x2.9x
Tue, 27 Aug 2024SEK 49.0bSEK 16.7b-SEK 986,735,355.0062.4x-49.7x2.9x
Thu, 25 Jul 2024SEK 48.3bSEK 16.6b-SEK 1,138,220,510.0060.8x-42.5x2.9x
Sat, 22 Jun 2024SEK 42.6bSEK 16.3b-SEK 1,188,686,510.0055x-35.9x2.6x
Mon, 20 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,529,510.0060.7x-35.5x2.6x
Wed, 17 Apr 2024SEK 38.3bSEK 16.0b-SEK 1,122,792,213.0035.3x-34.1x2.4x
Fri, 15 Mar 2024SEK 39.7bSEK 16.0b-SEK 1,123,139,210.0035.7x-35.4x2.5x
Sun, 11 Feb 2024SEK 39.7bSEK 15.8b-SEK 1,473,823,683.0056.5x-26.9x2.5x
Tue, 09 Jan 2024SEK 36.7bSEK 15.5b-SEK 1,393,723,683.0045.1x-26.4x2.4x
Thu, 07 Dec 2023SEK 36.6bSEK 15.5b-SEK 1,393,723,683.0044.1x-26.2x2.4x
Sat, 04 Nov 2023SEK 31.0bSEK 15.4b-SEK 1,256,647,710.0034.2x-24.7x2x
Mon, 02 Oct 2023SEK 26.8bSEK 15.1b-SEK 1,134,516,711.0039.8x-23.6x1.8x
Wed, 30 Aug 2023SEK 31.3bSEK 15.1b-SEK 1,138,067,831.0042.1x-27.5x2.1x
Fri, 28 Jul 2023SEK 33.0bSEK 14.9b-SEK 239,671,038.0047.5x-137.6x2.2x
Sun, 25 Jun 2023SEK 35.7bSEK 14.6b-SEK 172,476,038.0038.7x-207.1x2.4x
Price to Earnings Ratio

-207.1x


Total Market Cap: SEK 35.7bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 20.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market2.14%
Healthcare-1.60%
Life Sciences-2.35%
Clinical Research and Equipment-2.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LEVBIO Level BioSEK 0.3013.0%
+SEK 2.3m		-7.5%PS0.6x

Latest News

ATANA
SEK 0.005
Attana
7D
-16.7%
1Y
-77.3%
IDLDX
SEK 0.42
IDL Diagnostics
7D
-13.3%
1Y
-16.7%
MCAP
SEK 480.60
MedCap
7D
-5.4%
1Y
15.5%
MAGLE
SEK 1.03
Magle Chemoswed Holding
7D
-12.7%
1Y
-96.2%
PRO
SEK 10.40
Promimic
7D
-1.0%
1Y
-45.1%
LEVBIO
SEK 0.30
Level Bio
7D
13.0%
1Y
-7.5%
ALIF B
SEK 157.10
AddLife
7D
-0.4%
1Y
-18.6%
BICO
SEK 15.98
BICO Group
7D
-6.9%
1Y
-54.4%
GENO
SEK 18.50
Genovis AB (publ.)
7D
-7.5%
1Y
-31.4%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...